AcquisitionAug 29, 2026Pending
🇮🇱 Israel

LightSolver Ltd.CollPlant Biotechnologies Ltd.

Technology › Hardware & Electronics

Deal valueUndisclosed
AnnouncedAug 29, 2026
ConsiderationStock
StructureOther
RegionMiddle East & Africa
Cross-borderNo
Contingent paymentYes

Overview

CollPlant Biotechnologies Ltd. agreed to acquire all of the issued and outstanding share capital of LightSolver Ltd. from its current shareholders, paying with 3,734,476 ordinary shares, pre-funded warrants for 6,134,363 ordinary shares, three series of milestone-based warrants for up to 224,078,345 ordinary shares, and rollover options for 2,261,966 ordinary shares.

Deal rationale

The document states the acquisition moves CollPlant into the photonics market while it continues to evaluate and manage its existing regenerative and aesthetic medicine business.

AI-generated from the SEC filing
PendingTechnology › Hardware & ElectronicsIsraelMiddle East & Africa

Timeline

  1. AnnouncedAug 29, 2026

    Deal announced.

    Filing

Valuation and terms

Equity valueUndisclosed
Enterprise valueUndisclosed
ConsiderationStock

Advisors

Buy-side
HCH.C. Wainwright & Co.
Sell-side
None listed

Parties

Target
LightSolver Ltd.
Headquarters
Israel
Ticker
—
Acquirer
CollPlant Biotechnologies Ltd.
Headquarters
Israel
Ticker
—